CRT 2023
Ongoing Coronary Trials at the European Cardiovascular Research Institute (Non-CME) - Sponsored by Cardialysis
Adrian P. Banning, MD (he/him/his)
Prof Interventional cardiology Oxford University
Oxford University
Disclosure(s): Abbott: Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing)
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)